Humanized Control Antibodies for Infectious Disease Diagnostics

Understanding Infectious Diseases

Infectious diseases are caused by pathogenic microorganisms such as viruses, bacteria, parasites, fungi, and prions. These pathogens invade the human body, multiply within host tissues, and may disrupt normal physiological functions, leading to a wide range of clinical symptoms. Transmission can occur through direct contact between individuals or indirectly through contaminated food, water, environmental surfaces, or biological vectors such as mosquitoes and ticks. Many infectious diseases are also zoonotic, meaning they originate in animals and can be transmitted to humans.

Despite major advances in medicine, infectious diseases remain a significant global health challenge. Emerging pathogens, antimicrobial resistance, and increasing international travel all contribute to the continued spread of infectious agents. Rapid detection and accurate diagnosis are therefore critical for timely treatment, outbreak control, and public health surveillance.

Fig.1 Types of Infections

Major categories of infectious diseases include:

Viral infections – COVID-19, Influenza, HIV, Dengue, Hepatitis B & C

Viruses invade host cells and utilize the host cellular machinery to replicate. Newly formed viral particles are released from infected cells and spread to additional host cells. Some viruses cause direct cell damage, while others alter cellular function or induce abnormal cell proliferation.

Bacterial infections – Tuberculosis, Salmonellosis, Lyme disease

Bacteria are single-celled microorganisms widely distributed in nature and within the human body. Pathogenic bacteria can infect nearly any tissue or organ, leading to localized or systemic infections.

Parasitic infections – Malaria, Leishmaniasis

Parasites depend on host organisms for survival. Certain parasites cause minimal symptoms, while others invade tissues, replicate within the host, and result in severe disease.

Fungal infections – Candidiasis, Histoplasmosis

Fungi include yeasts, molds, and other organisms that may naturally exist on human skin or within the body. Opportunistic fungal infections can become life-threatening in immunocompromised individuals.

Prion Diseases

Prion diseases are rare but serious infectious disorders caused by misfolded proteins known as prions. Examples include Creutzfeldt-Jakob disease (CJD), fatal insomnia, kuru, and variably protease-sensitive prionopathy.

Infectious diseases remain a major global health challenge and are among the leading causes of death worldwide. Early detection and accurate diagnosis are essential for effective treatment, outbreak control, and prevention of disease transmission.

Advantages of Humanized Control Antibodies

Humanized control antibodies are recombinant antibodies engineered to mimic naturally occurring human antibodies against infectious disease targets. They serve as standardized positive controls for assay development, validation, and routine quality control.

Compared with traditional serum-derived controls, humanized control antibodies provide several important advantages:

Serum-Free Production

These antibodies are produced using recombinant expression systems without animal-derived serum components. This approach reduces contamination risks, minimizes background interference, and improves reagent purity.

High Stability and Batch Consistency

Recombinant antibody technology ensures precise control of antibody sequences and structures, resulting in minimal lot-to-lot variation. The antibodies are designed for long-term stability during storage and transportation, ensuring consistent assay performance.

Reliable Performance Across Diagnostic Platforms

Humanized control antibodies are compatible with a wide range of immunoassay technologies, including ELISA, CLIA, chemiluminescent platforms, and rapid diagnostic tests such as lateral flow assays.

Scalable and Cost-Effective Supply

Unlike human serum controls, recombinant antibodies can be produced in large quantities with consistent quality. This ensures stable supply chains for diagnostic kit manufacturers and clinical laboratories.

Creative Diagnostics currently offers over 200 humanized control antibodies for infectious disease diagnostics, covering more than 50 clinically relevant pathogens, including viral, bacterial, parasitic, and fungal targets.